POMT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A2 Genetic Test sale cost 4400 AED
DYSF Gene Miyoshi Myopathy Genetic Test sale cost 4400 AED DYSF Gene Miyoshi Myopathy Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
DRD2 Gene Myoclonic Dystonia DRD2 Related Genetic Test sale cost 4400 AED DRD2 Gene Myoclonic Dystonia DRD2 Related Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

POMT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The POMT2 gene plays a crucial role in the development and function of muscles and the brain. Mutations in this gene can lead to a form of muscular dystrophy-dystroglycanopathy, specifically categorized as Congenital with Brain and Eye Anomalies Type A2 (MDDGA2). This condition is characterized by muscle weakness, developmental delays, and abnormalities in the brain and eyes from birth. Genetic testing for mutations in the POMT2 gene is essential for diagnosing this disorder, enabling early intervention and management of symptoms.

DNA Labs UAE offers a comprehensive genetic test to identify mutations in the POMT2 gene, providing crucial information for affected families. The test is priced at 4400 AED and involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory. Results from this test can help in confirming the diagnosis, understanding the severity of the condition, and informing treatment options. It also aids in genetic counseling, offering families insights into the risk of the condition recurring in future pregnancies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

POMT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A2 Genetic Test

Test Details

The POMT2 gene is associated with a type of muscular dystrophy called muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2. This condition is characterized by muscle weakness and wasting, along with brain and eye abnormalities. The NGS (Next-Generation Sequencing) genetic test is a type of genetic testing that can analyze multiple genes simultaneously. In the case of POMT2 gene testing, NGS can identify any variations or mutations in the POMT2 gene that may be causing the condition. This genetic test can help in confirming a diagnosis of muscular dystrophy-dystroglycanopathy, type A2 and can also be useful for carrier testing in individuals with a family history of the condition. It can provide valuable information for genetic counseling, management, and treatment options. It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics, as they can provide appropriate counseling and guidance based on the test results.

Test Name

POMT2 Gene Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A2 Genetic Test

Components

  • Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Neurological Disorders

Doctor

Neurologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for POMT2 Gene Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with POMT2 Gene Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2.

Test Name POMT2 Gene Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for POMT2 Gene Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with POMT2 Gene Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2
Test Details

The POMT2 gene is associated with a type of muscular dystrophy called muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2. This condition is characterized by muscle weakness and wasting, along with brain and eye abnormalities.

The NGS (Next-Generation Sequencing) genetic test is a type of genetic testing that can analyze multiple genes simultaneously. In the case of POMT2 gene testing, NGS can identify any variations or mutations in the POMT2 gene that may be causing the condition.

This genetic test can help in confirming a diagnosis of muscular dystrophy-dystroglycanopathy, type A2 and can also be useful for carrier testing in individuals with a family history of the condition. It can provide valuable information for genetic counseling, management, and treatment options.

It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics, as they can provide appropriate counseling and guidance based on the test results.

SKU: TEST-1758 Category:

Related products